Compare Janus Living Inc. Class A-1 Common Stock (JAN) vs Lam Research Corporation (LRCX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Janus Living Inc. Class A-1 Common Stock vs Lam Research Corporation — how do they compare? Janus Living Inc. Class A-1 Common Stock trades at $28.51 (market cap $6.79B), while Lam Research Corporation trades at $279 (market cap $359.06B). The key difference: Lam Research Corporation is far larger — about 52.9× Janus Living Inc. Class A-1 Common Stock's market cap, and Janus Living Inc. Class A-1 Common Stock pays the higher dividend (1.97%). Which is the better fit depends on your goals — on Pluang, investors hold Janus Living Inc. Class A-1 Common Stock for 0 Days and Lam Research Corporation for 61 Days on average.
| JAN | LRCX | |
|---|---|---|
Market Cap | $6.79B | $359.06B |
Volume | 1,802,875 | 10,336,294 |
Sector | Real Estate | Technology |
52-Week High | $31.76 | $433.33 |
52-Week Low | $22.88 | $139.59 |
Typical Hold Time | 0 Days | 61 Days |
Enterprise Value | $6.88B | $357.21B |
Dividend Yield | 1.97% | 0.46% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JAN trades at $28.85, up 0.42% today, with a neutral technical signal. The company, a senior housing REIT, reported a net loss of $61.10M in 2025, though revenue grew to $771.17M. Analyst sentiment is strongly positive with a 100% buy rating and a $32.91 consensus price target, representing a 14% upside. Recent developments include closing a $1.25 billion credit facility and declaring quarterly dividends.
The outlook is cautiously optimistic, driven by strong analyst support and strategic growth initiatives. Key opportunities include accretive acquisitions funded by recent capital raises. Risks include persistent negative profit margins, execution challenges in integrating new assets, and sensitivity to interest rate changes affecting REIT valuations.
Lam Research (LRCX) trades at $301.11, down 2.73% on the day, amid a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results pending. Revenue grew to $18.44B in 2025, with a net income margin of 31.27% and robust cash flow from operations of $6.17B. Analyst sentiment remains overwhelmingly positive, with a consensus price target of $375.68.
LRCX presents a compelling long-term opportunity driven by AI-driven semiconductor equipment demand, though near-term technical weakness and high valuation multiples pose risks. The company's strategic positioning in advanced chip manufacturing supports growth, but investors should monitor execution against earnings expectations and competitive dynamics in the semiconductor equipment sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Janus Living Inc. Class A-1 Common Stock
Janus Living, Inc. is a real estate investment trust that owns and operates senior housing communities in US. Its portfolio comprises roughly 34 communities across 10 states, structured under RIDEA arrangements and externally managed by Healthpeak Investment Management.
Read more on JAN →About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Read more on LRCX →
